Exploiting senescence for the treatment of cancer
L Wang, L Lankhorst, R Bernards - Nature Reviews Cancer, 2022 - nature.com
Senescence is a cellular response to a variety of stress signals that is characterized by a
stable withdrawal from the cell cycle and major changes in cell morphology and physiology …
stable withdrawal from the cell cycle and major changes in cell morphology and physiology …
[PDF][PDF] Meta-hallmarks of aging and cancer
Both aging and cancer are characterized by a series of partially overlapping" hallmarks" that
we subject here to a meta-analysis. Several hallmarks of aging (ie, genomic instability …
we subject here to a meta-analysis. Several hallmarks of aging (ie, genomic instability …
[PDF][PDF] Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity
K Hezaveh, RS Shinde, A Klötgen, MJ Halaby… - Immunity, 2022 - cell.com
The aryl hydrocarbon receptor (AhR) is a sensor of products of tryptophan metabolism and a
potent modulator of immunity. Here, we examined the impact of AhR in tumor-associated …
potent modulator of immunity. Here, we examined the impact of AhR in tumor-associated …
Metabolic communication in the tumour–immune microenvironment
KC Kao, S Vilbois, CH Tsai, PC Ho - Nature Cell Biology, 2022 - nature.com
The metabolically hostile tumour microenvironment imposes barriers to tumour-infiltrating
immune cells and impedes durable clinical remission following immunotherapy. Metabolic …
immune cells and impedes durable clinical remission following immunotherapy. Metabolic …
Cellular senescence is immunogenic and promotes antitumor immunity
I Marin, O Boix, A Garcia-Garijo, I Sirois, A Caballe… - Cancer discovery, 2023 - AACR
Cellular senescence is a stress response that activates innate immune cells, but little is
known about its interplay with the adaptive immune system. Here, we show that senescent …
known about its interplay with the adaptive immune system. Here, we show that senescent …
Roles of IFN-γ in tumor progression and regression: a review
D Jorgovanovic, M Song, L Wang, Y Zhang - Biomarker research, 2020 - Springer
Background Interferon-γ (IFN-γ) plays a key role in activation of cellular immunity and
subsequently, stimulation of antitumor immune-response. Based on its cytostatic, pro …
subsequently, stimulation of antitumor immune-response. Based on its cytostatic, pro …
[HTML][HTML] CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours
B Kruse, AC Buzzai, N Shridhar, AD Braun, S Gellert… - Nature, 2023 - nature.com
Most clinically applied cancer immunotherapies rely on the ability of CD8+ cytolytic T cells to
directly recognize and kill tumour cells,–. These strategies are limited by the emergence of …
directly recognize and kill tumour cells,–. These strategies are limited by the emergence of …
p21 produces a bioactive secretome that places stressed cells under immunosurveillance
I Sturmlechner, C Zhang, CC Sine, EJ van Deursen… - Science, 2021 - science.org
INTRODUCTION Complex multicellular organisms are subject to a myriad of cellular
stresses, which can be managed through cell-intrinsic adaptation and repair mechanisms …
stresses, which can be managed through cell-intrinsic adaptation and repair mechanisms …
ROS in cancer therapy: the bright side of the moon
Reactive oxygen species (ROS) constitute a group of highly reactive molecules that have
evolved as regulators of important signaling pathways. It is now well accepted that moderate …
evolved as regulators of important signaling pathways. It is now well accepted that moderate …
CD8+ T cell states in human cancer: insights from single-cell analysis
AM Van der Leun, DS Thommen… - Nature Reviews …, 2020 - nature.com
The T cell infiltrates that are formed in human cancers are a modifier of natural disease
progression and also determine the probability of clinical response to cancer …
progression and also determine the probability of clinical response to cancer …